GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little evidence of improving cardiorespiratory fitness, researchers say.

Figma disclosed preliminary results for the second quarter showing revenue growth between 39% and 41% year over year.

Puerto Rico’s GAVYM drone network aims to modernize services and reduce disaster risks across the island. #NewsismyBusiness ...